News Alert: FDA details new risk with heart pump controllers after patient’s death | Cardiovascular Business

Home

Recent Newsletters

Week in Review: Reprocessed catheters recalled | ECG market keeps evolving | Experimental pill impresses | AF Symposium 2026

Choosing PET over SPECT | CCTA & low-risk patients | Medtronic makes a move | Reducing invasive catheterizations | AI for POCUS

A major benefit of CCTA | MRI scans for heart failure risk | A fresh approach to redo TAVR planning | Imaging registry expands

IVL may be safer than atherectomy | Impella use in elderly patients | Radiation in the cath lab | New-look device makes US debut

Key details about Lp(a) | TAVR momentum for Edwards | New scaffold shows promise | Progress for heart catheter | $50M donated

TAVR Highlights: Major changes on the way? | Medtronic invests $90M | Judge blocks JenaValve acquisition | New stroke data

Reprocessed EP catheters recalled | TAVR outcomes for men & women | The evolving ECG market | Updated instructions | PE research

Design by Adaptive Theme